BK virus risk study in kidney transplant patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at the type and genetic makeup of BK virus in kidney transplant patients and their donors. It aims to find patients at higher risk for a kidney infection caused by the virus, which could help improve monitoring and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a kidney transplant at least 3 months ago, but less than 2 years ago.
- You have had a positive test for BK virus in your urine with a high viral load (more than 3 log copies per mL).
- You are at least 18 years old.
- You are being followed at Grenoble Alpes University Hospital.
- You have health insurance coverage in France.
- You agree to have your data and samples used for this research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system reacts to the BK virus in people who have had a kidney transplant. It may help doctors understand why some patients develop the virus in their blood and how to better manage it.
This study is creating a registry to learn how the immune system responds to BK virus in people who have recently received a kidney transplant from a deceased donor. Researchers hope this information will help improve treatment for BK virus infections.
This study tests a new medicine (AIC468) to see if it can help clear BK virus from the blood of people who have recently had a kidney transplant. Participants will receive either the study drug or a placebo (a dummy pill) to compare outcomes.
This study checks whether BK virus, which can cause problems after a kidney transplant, is found in saliva. It may help find a simpler way to monitor patients.
This early-phase study tests whether immune cells made from a donor (T cells) can treat BK virus infection in people whose immune system is weak after a stem cell transplant or chemotherapy. It may help control the virus causing bladder/urinary symptoms.
This study tests a new treatment using lab-made antibodies to treat BK virus infection. It may help by controlling the virus in adults who already test BK positive.
Hear when a new Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.